- Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch, Epperson C.N., Toll B., Wu R., Amin Z., Czarkowski K.A., Jatlow P., et al., p. 1-8.
- Gender differences in the relationship of internalizing and externalizing psychopathology to alcohol dependence: Likelihood, expression and course, Dawson D.A., Goldstein R.B., Moss H.B., Li T.-K., Grant B.F., p. 9-17.
- Neighborhood education inequality and drinking behavior, Lê F., Ahern J., Galea S., p. 18-26.
- Processing dynamic facial affect in frequent cannabis-users: Evidence of deficits in the speed of identifying emotional expressions, Platt B., Kamboj S., Morgan C.J.A., Curran H.V., p. 27-32.
- Ecstasy use among US adolescents from 1999 to 2008, Wu P., Liu X., Pham T.H., Jin J., Fan B., Jin Z., p. 33-38.
- Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults, Cornelius J.R., Bukstein O.G., Douaihy A.B., Clark D.B., Chung T.A., Daley D.C., et al., p. 39-45.
- Exposure to trauma: A comparison of cocaine-dependent cases and a community-matched sample, Afful S.E., Strickland J.R., Cottler L., Bierut L.J., p. 46-53.
- Risk-taking but not response inhibition or delay discounting predict alcohol consumption in social drinkers, Fernie G., Cole J.C., Goudie A.J., Field M., p. 54-61.
- Methadone maintenance treatment: A protective factor for cocaine injection in a street-recruited cohort of heroin users, Bravo M.J., Llorens N., Barrio G., Brugal M.T., Santos S., Sordo L., et al., p. 62-68.
- Subtypes of nonmedical opioid users: Results from the national epidemiologic survey on alcohol and related conditions, Wu L.-T., Woody G.E., Yang C., Blazer D.G., p. 69-80.
- Effects of practitioner-delivered brief counseling and computer-generated tailored letters on cigarettes per day among smokers who do not quit--A quasi-randomized controlled trial, Klein G., Ulbricht S., Haug S., Gross B., Rumpf H.-J., John U., et al., p. 81-89.
- Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP Study, Edlund M.J., Martin B.C., Fan M.-Y., Devries A., Braden J.B., Sullivan M.D., p. 90-98.
- Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics, Wilsey B.L., Fishman S.M., Gilson A.M., Casamalhuapa C., Baxi H., Zhang H., et al., p. 99-106.
- Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes, Ye L., Wang S., Wang X., Zhou Y., Li J., Persidsky Y., et al., p. 107-116.
- Does heavy adolescent marijuana use lead to criminal involvement in adulthood? Evidence from a multiwave longitudinal study of urban African Americans, Green K.M., Doherty E.E., Stuart E.A., Ensminger M.E., p. 117-125.
- Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by [Delta]9-tetrahydrocannabinol, Delong G.T., Wolf C.E., Poklis A., Lichtman A.H., p. 126-133.
- A serotonin transporter polymorphism (5-HTTLPR) predicts the development of adolescent alcohol use, Van Der Zwaluw C.S., Engels R.C.M.E., Vermulst A.A., Rose R.J., Verkes R.J., Buitelaar J., et al., p. 134-139.
- Personal network correlates of alcohol, cigarette, and marijuana use among homeless youth, Wenzel S.L., Tucker J.S., Golinelli D., Green Jr H.D., Zhou A., p. 140-149.
- Prevalence and correlates of specialty substance use disorder treatment for Department of Veterans Affairs Healthcare System patients with high alcohol consumption, Glass J.E., Perron B.E., Ilgen M.A., Chermack S.T., Ratliff S., Zivin K., p. 150-155.
- Gender and NAS: Does sex matter?, Holbrook A., Kaltenbach K., p. 156-159.
- Alcohol consumption patterns in HIV-infected adults with alcohol problems, Bertholet N., Cheng D.M., Samet J.H., Quinn E., Saitz R., p. 160-163.
- Lack of inhibitory control predicts cigarette smoking dependence: Evidence from a non-deprived sample of light to moderate smokers, Billieux J., Gay P., Rochat L., Khazaal Y., Zullino D., Van Der Linden M., p. 164-167.
- Zolpidem does not serve as reinforcer in humans subjected to simulated shift work, Kirkpatrick M.G., Haney M., Vosburg S.K., Comer S.D., Foltin R.W., Hart C.L., p. 168-171.